Study to improve HIV prevention habits in young gay and bisexual men
Part of Infections clinical trials.
This study tests a new approach to help young gay and bisexual men who take PrEP medication prevent HIV but sometimes miss doses or have condomless sex. It aims to see if behavioral strategies can improve adherence to PrEP and reduce risky behaviors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 34 years old.
- You are HIV-negative (confirmed by a quick test).
- You identify as gay or bisexual.
- You have used methamphetamine in the past 3 months.
- You are currently prescribed and taking PrEP medication to prevent HIV.
- You have missed some doses of PrEP in the past 3 months and have had condomless anal sex or a sexually transmitted infection in that time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests ways to help Latino men who have sex with men use PrEP, a medicine that helps prevent HIV. You may be invited if you are HIV-negative (or your status is unknown), are not currently on PrEP, and can read and write Spanish.
This study tests a support program to help people stick with PrEP, a daily pill that prevents HIV. If you've stopped taking PrEP or are thinking about restarting, this program may help you stay protected.
This study tests an all-in-one HIV prevention package for young men at higher risk of HIV. It combines a new long-acting PrEP (injectable HIV prevention) with mobile health support and sexually transmitted infection prevention. The goal is to see if this comprehensive approach works better than standard care.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.